Clinical Trials Browser

Small Cell Lung Carcinoma × berzosertib × 90 days × Clear all

NCT03896503 2026-03-19

Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

Phase 2 Active not recruiting

104 enrolled 22 charts

Small Cell Lung Carcinoma

NCT04802174 2026-03-17

Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers

Phase 1/2 Active not recruiting

Small Cell Lung Carcinoma